GHRP-2
Synthetic hexapeptide ghrelin mimetic. GHSR-1a agonist studied in growth-hormone-release research.
Synthetic hexapeptide ghrelin mimetic. GHSR-1a agonist studied in growth-hormone-release research.
The primary literature on this compound includes Bowers et al., Endocrinology (1991). The references below link directly to the published record.
Every lot is synthesized in the USA, verified by HPLC, and ships with its Certificate of Analysis. It is supplied strictly for laboratory research use.
Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it is not approved by the FDA for human or veterinary use, and nothing here is a protocol or a recommendation.
Researchers also ordered
- CJC-1295 (no DAC)Modified GHRH (1-29) analog without drug-affinity complex. Short half-life GH-axis research peptide.
- CJC-1295 with DAC 5mgGHRH analog with drug-affinity complex. Extended-half-life GH-axis research peptide.
- GHRP-6Hexapeptide ghrelin mimetic with appetite-research activity. GHSR-1a agonist.
- IGF-1 LR3 1mgLong Arg3 IGF-1 — research-volume vial.